Kolon Life Science
Gwacheon, South Korea
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (6)
○ EMA GMP
○ MHRA GMP
Quick Facts: Kolon Life Science
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Gwacheon, South Korea
- Website
- https://www.kolonls.co.kr/eng/chemical/business?b=1
- Modalities
- Small Molecule API, Intermediates, Oligonucleotide, High-Potency APIs
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Kolon Life Science
Kolon Life Science makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Oligonucleotide, High-Potency APIs. 2 manufacturing sites registered with the U.S. FDA. Website: https://www.kolonls.co.kr/eng/chemical/business?b=1
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 6 articles
Company announcements, not verified evidence. They do not change any score.
Kolon Life Science Wins KLS-3021 Patent Approvals - Businesskorea
Kolon Life Science Wins KLS-3021 Patent Approvals Businesskorea
Kolon Life Science Wins Patent Rulings for Oncolytic Virus Production - Seoul Economic Daily
Kolon Life Science Wins Patent Rulings for Oncolytic Virus Production Seoul Economic Daily
Kolon Life Science wins Korea, U.S., Australia patents for cancer virus production - Chosunbiz
Kolon Life Science wins Korea, U.S., Australia patents for cancer virus production Chosunbiz
Kolon Life Science Receives Patent Grant Decisions in Korea, U.S., and Australia for Gene Therapy Production Technology - 아시아경제
Kolon Life Science Receives Patent Grant Decisions in Korea, U.S., and Australia for Gene Therapy Production Technology 아시아경제
Kolon Life Science to Expand PPO Production Capacity for Semiconductor Materials - THE ELEC, Korea Electronics Industry Media
Kolon Life Science to Expand PPO Production Capacity for Semiconductor Materials THE ELEC, Korea Electronics Industry Media
Kolon Life Science Expands Output of Key Material for AI Chips - Seoul Economic Daily
Kolon Life Science Expands Output of Key Material for AI Chips Seoul Economic Daily
Frequently Asked Questions About Kolon Life Science
Does Kolon Life Science have a CDMO Signal Score?
Not yet. Kolon Life Science is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Kolon Life Science for a manufacturing program?
Use the free AI matchmaker to compare Kolon Life Science against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
ChemExpress
Shanghai, China
Small Molecule API, Intermediates, High-Potency APIs, ADC / Bioconjugation, Peptides, Oligonucleotide
Juzen Chemical
Toyama, Japan
Small Molecule API, Intermediates, High-Potency APIs, Oligonucleotide
Yuhan Chemical
Ansan, Gyeonggi-do, South Korea
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
Axplora
Paris, France
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
Shanghai Desano
Shanghai, China
Small Molecule API, Intermediates, Oral Solid Dose, Oligonucleotide
Compare Kolon Life Science with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.